REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

Thu, 02nd Dec 2021 09:52

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

DEUTSCHE BANK RAISES NATIONAL GRID PRICE TARGET TO 1,050 (1,020) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES UNITED UTILITIES PRICE TARGET TO 1,100 (1,050) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES SEVERN TRENT PRICE TARGET TO 3,100 (2,900) PENCE - 'BUY'

----------

RBC RAISES NATWEST PRICE TARGET TO 280 (260) PENCE - 'OUTPERFORM'

----------

RBC RAISES LLOYDS PRICE TARGET TO 60 (54) PENCE - 'OUTPERFORM'

----------

RBC RAISES HSBC PRICE TARGET TO 530 (490) PENCE - 'OUTPERFORM'

----------

MORGAN STANLEY RAISES HSBC PRICE TARGET TO 484 (460) PENCE - 'EQUAL-WEIGHT'

----------

RBC RAISES BARCLAYS PRICE TARGET TO 210 (190) PENCE - 'SECTOR PERFORM'

----------

JPMORGAN CUTS BERKELEY GROUP PRICE TARGET TO 5,500 (5,848) PENCE - 'OVERWEIGHT'

----------

GOLDMAN CUTS SCHRODERS PRICE TARGET TO 3110 (3120) PENCE - 'SELL'

----------

FTSE 250

----------

CITIGROUP CUTS DRAX GROUP TO 'NEUTRAL' (BUY) - PRICE TARGET 651 (575) PENCE

----------

BANK OF AMERICA RAISES WORKSPACE GROUP TO 'BUY' (NEUTRAL) - PRICE TARGET 1,010 (1,000) PENCE

----------

JPMORGAN RAISES AUCTION TECHNOLOGY GROUP TARGET TO 1,687 (1,520) P - 'OVERWEIGHT'

----------

DEUTSCHE BANK RAISES PENNON GROUP PRICE TARGET TO 1,260 (1,180) PENCE - 'HOLD'

----------

RBC RAISES PARAGON GROUP PRICE TARGET TO 630 (540) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES OSB GROUP PRICE TARGET TO 700 (650) PENCE - 'OUTPERFORM'

----------

RBC RAISES VIRGIN MONEY PRICE TARGET TO 220 (200) PENCE - 'SECTOR PERFORM'

----------

RBC CUTS CLOSE BROTHERS PRICE TARGET TO 1,450 (1,600) PENCE - 'SECTOR PERFORM'

----------

GOLDMAN SACHS RAISES MAN GROUP PRICE TARGET TO 230 (220) PENCE - 'NEUTRAL'

----------

BERENBERG CUTS EASYJET PRICE TARGET TO 750 (800) PENCE - 'BUY'

----------

JEFFERIES CUTS COUNTRYSIDE PROPERTIES PRICE TARGET TO 606 (642) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

BANK OF AMERICA RAISES OLD MUTUAL TO 'BUY' (NEUTRAL)

----------

LIBERUM CUTS CLINIGEN PRICE TARGET TO 780 (800) PENCE - 'BUY'

----------

LIBERUM RAISES PENDRAGON PRICE TARGET TO 21 (20) PENCE - 'HOLD'

----------

BERENBERG RAISES IMPAX ASSET MANAGEMENT TARGET TO 1,500 (1,400) PENCE - 'BUY'

----------

RBC CUTS TRIPLE POINT ENERGY EFFICIENCY INFRASTRUCTURE TO 'SECTOR PERFORM' ('OUTPERFORM') TARGET 105 (110) PENCE

----------

RBC RAISES SUPERDRY TO 'OUTPERFORM' (SECTOR PERFORM) - PRICE TARGET 425 (390) PENCE

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
14 Jul 2020 09:07

Clinigen FY revenues continue to rise, profit growth slowed by Covid-19

(Sharecast News) - Pharmaceutical group Clinigen warned full-year profit growth would be at the lower end of guidance as a result of the Covid-19 pandemic and the launch of a low-cost competitor to its Foscavir drug.

Read more
13 Jul 2020 16:29

Clinigen gets orphan drug designation for 'aldesleukin' in the US

(Sharecast News) - Pharmaceutical services company Clinigen Group announced on Monday that the US Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has granted orphan drug designation for 'aldesleukin', in the treatment of amyotrophic lateral sclerosis (ALS).

Read more
13 Jul 2020 13:48

Monday broker round-up

(Sharecast News) - Kingfisher: RBC Capital Markets reiterates outperform with a target price of 275.0p

Read more
13 Jul 2020 08:41

Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin

Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin

Read more
14 Jun 2020 19:22

Sunday newspaper round-up: Two meters, Rolls Royce, Clinigen

(Sharecast News) - Senior scientists have reported flaws in an influential World Health Organization-commissioned study into the risks of coronavirus infection and say it should not be used as evidence for relaxing the UK's 2-metre physical distancing rule. Critics of the distancing advice, which states that people should keep at least 2 metres apart, believe it is too cautious. They seized on the research commissioned by the WHO, which suggested a reduction from 2 metres to 1 would raise infection risk only marginally, from 1.3% to 2.6%. - Guardian

Read more
28 May 2020 13:34

Thursday broker round-up

(Sharecast News) - Provident Financial: RBC Capital Markets reiterates sector performer with a target price of 195p.

Read more
28 May 2020 09:37

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

Read more
26 May 2020 17:50

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Read more
12 May 2020 10:37

McCarthy & Stone CFO Rowan Baker Defects To Laing O'Rourke

McCarthy & Stone CFO Rowan Baker Defects To Laing O'Rourke

Read more
16 Apr 2020 12:00

Clinigen Says Annual Trading In Line; Signs Erwinase License Agreement

Clinigen Says Annual Trading In Line; Signs Erwinase License Agreement

Read more
24 Mar 2020 16:00

DIRECTOR DEALINGS SUMMARY: Pearson And IHG Chairs Buy Amid Virus Pain

DIRECTOR DEALINGS SUMMARY: Pearson And IHG Chairs Buy Amid Virus Pain

Read more
20 Mar 2020 09:49

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

Read more
18 Mar 2020 13:42

Wednesday broker round-up

(Sharecast News) - Polypipe: Deutsche Bank upgrades to buy with a target price of 550p.

Read more
12 Mar 2020 16:05

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
11 Mar 2020 13:37

Wednesday broker round-up

(Sharecast News) - Clinigen Group: Liberum upgrades to buy with a target price of 780.0p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.